PRESS RELEASE
News
-
-
PRESS RELEASE
Ondine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced Mupirocin
Study at Mazankowski Alberta Heart Institute shows 32% reduction in cardiac infections with Steriwave replacing antibiotic standard. Significant cost savings and high compliance. Expert commentary available -
-
-
-
REGULATED PRESS RELEASE
Aéroports de Paris SA - Filing of the 2023 Universal Registration Document
Aéroports de Paris SA filed the 2023 Universal Registration Document with AMF. Documents include financial report, corporate governance report, share buyback program description, management report, auditors' reports, and fees information -
-
-
REGULATED PRESS RELEASE
Biophytis dépose une demande de brevet et renforce sa propriété intellectuelle dans l’obésité
Biophytis renforce sa propriété intellectuelle en déposant une demande de brevet pour le traitement de l’obésité, soulignant le potentiel de BIO101 (20-hydroxyecdysone) sur un marché en pleine croissance -
REGULATED PRESS RELEASE
Biophytis files a patent application and strengthens its intellectual property in obesity
Biophytis files a patent application to strengthen its intellectual property in obesity. The new patent extends BIO101's exclusivity period in treating obesity, positioning Biophytis in a fast-growing market
